Ci Private Wealth, LLC Iovance Biotherapeutics, Inc. Transaction History

Ci Private Wealth, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	SELL	$7.59 - $17.47 $1.93 Million - $4.45 Million	-254,738 Reduced 69.41%	112,262 $1.66 Million
Q4 2023 Feb 09, 2024	BUY	$3.3 - $8.89 $815,756 - $2.2 Million	247,199 Added 206.34%	367,000 $2.98 Million
Q3 2023 Nov 03, 2023	SELL	$4.44 - $8.79 $407,756 - $807,247	-91,837 Reduced 43.39%	119,801 $545,000
Q2 2023 Aug 10, 2023	BUY	$5.36 - $9.06 $1.13 Million - $1.92 Million	211,638 New	211,638 $1.49 Million

323

239M

1.27M

1.68M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.65B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Ci Private Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Ci Private Wealth, LLC with notifications on news.